Summary: According to Dr Roch Doliveux (MBA ‘81J), CEO of UCB, "the issue of access to medicine is an issue surprisingly both in the developed market and in the so-called emerging market, ‘so-called’ because we can’t talk about China, the second largest economy in the world, as emerging. I would say it has emerged already."
